Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

11 avr. 2025 07h00 HE | Source: Nutriband Inc.

Nutriband Granted Patent in Macao for its AVERSA Abuse Deterrent Transdermal Technology

Nutriband increases Patent protection with the addition of Macao
21 févr. 2025 07h00 HE | Source: Nutriband Inc.

Nutriband Receives Certificate of Registration for Trademark covering Pharmaceutical and Product Research and Development.

Issued new Trademark
13 févr. 2025 07h00 HE | Source: Nutriband Inc.

Nutriband and Kindeva Drug Delivery Formalize Exclusive Development Partnership for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch

Partnership Agreement
11 févr. 2025 09h00 HE | Source: Nutriband Inc.

Nutriband Inc. Announces Olympian Anastasia Nichita to Advisory Board

ORLANDO, Fla., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (the “Company”)(NASDAQ:NTRB)(NASDAQ:NTRBW), a developer of transdermal pharmaceutical products, today announced World and European...
07 févr. 2025 08h45 HE | Source: Nutriband Inc.

Nutriband Receives Notice Of Allowance For New U.S. Patent Covering Its Transdermal Abuse Deterrent Technology Aversa™

U.S. Patent Office issues Notice of Allowance for new patent covering Nutriband's AVERSA™ technology
31 déc. 2024 07h00 HE | Source: Nutriband Inc.

Nutriband Issues Letter to Shareholders

CEO Publishes Letter to Shareholders looking over achievements in 2024 and outlook for 2025
27 déc. 2024 09h25 HE | Source: Nutriband Inc.

Nutriband Extends Chinese Patent to Macao for its AVERSA™ Abuse Deterrent Transdermal Technology

Chinese Patent for AVERSA extended to Macao